uMammo 890i pioneers a new breakthrough in low-dose, high resolution breast imaging.The CMOS Starlight imaging platform is equipped with dual-angle 3D breast imaging and U-View synthetic 2D technology, greatly increasing the early detection rate of breast cancer while reducing dose by 41%. Together with uStereo stereotaxic biopsy device, it provides a complete solution for early screening, accurate diagnosis, and biopsy positioning of breast cancer, caring for the need of every woman.
Dual Angle Tomography
U-View 2D Synthetic Imaging
uStereo Stereotaxic Biopsy System*
Women's Health Community Supported by Hologic
Comprehensive information on women’s health issues and management, management and personalisation.
Enterprise Imaging Community
Advanced and scalable radiology solutions that can help improve care coordination, increase speed and facilitate accurate clinical decisions.
Decision Support Community
Leading the way in highlighting useful and efficient decision support tools for improved patient outcomes.
Sepsis Community Supported by Abionic
Addressing the latest developments in sepsis and providing clinically useful information for diagnosis and treatment of patients.
Hologic & Bayer Partner for Global Enhanced Mammography Solutions to Imaging Centers
Partnership Includes Education and Training to Increase Clinician Confidence... Read more
Straumann Group Acquires AlliedStar, an Intraoral Scanner Provider in China
Straumann Group to acquire AlliedStar to complement its intraoral scanner... Read more
FP Markets Claims a Hat-Trick for a Second Time in a Row at the Global Forex Awards 2023
FP Markets Claims a Hat-Trick for a Second Time in a Row at the Global... Read more
Next-Generation PET/CT Systems and Molecular Technology Platform by United Imaging
Pioneering a new era of nuclear medicine and molecular imaging through... Read more
Hospital Management Meets Elite Sports Teams in Virtual Roundtable
Canon Medical proudly announces an insightful roundtable discussion on... Read more
JOIN OUR MANAGEMENT COMMUNITY